The U.S. State Department has agreed to release funding for Gavi, the Vaccine Alliance, after having begun to phase out its support for the organization, according to CIDRAP. The decision reverses a trajectory set earlier in the Trump administration, which had intended to terminate U.S. financial support for Gavi — the public-private partnership that pools donor funds to negotiate lower vaccine prices and expand immunization in low-income countries. The New York Times previously reported on the planned termination.

The reinstatement follows a contentious review period. In mid-2025, U.S. Health and Human Services Secretary Kennedy announced that the United States would not provide additional funding to Gavi unless the organization changed its evaluation of vaccine science, according to KFF. That conditional stance effectively froze U.S. contributions during a fiscal year when Gavi was already navigating competing global health priorities and mounting pressure on donor governments.

Gavi relies on donor contributions as the core of its financing model, and the United States has historically ranked among its largest government donors. Prior USAID contributions to Gavi supported COVAX, the facility designed to provide equitable access to COVID-19 vaccines for the world's most vulnerable and at-risk populations, per a USAID OIG report.

The broader context here is one of oscillation in U.S. global health funding. The State Department's agreement to disburse Gavi funding follows the administration's June 2026 announcement of more than $1 billion in humanitarian and disaster response assistance to UNICEF and the World Food Programme, as detailed by the U.S. Embassy in China. Of that package, $93 million was channeled through UNICEF to transport and distribute ready-to-use therapeutic food, according to the U.S. Embassy in Gaborone. The World Food Programme welcomed the contribution, noting it would support food and nutrition operations reaching more than 38 million vulnerable people.

These two funding streams — Gavi for immunization and WFP/UNICEF for food and nutrition — operate through different bureaucratic channels and answer to different policy imperatives, but they share an audience: the same low-income populations whose health outcomes depend on both adequate nutrition and vaccine access. The U.S. decision to resume Gavi funding while simultaneously scaling food assistance suggests a selective re-engagement with multilateral health architecture rather than a blanket withdrawal or a blanket return.

The conditions attached to the reinstatement are worth weighing carefully. Secretary Kennedy's demand that Gavi change its evaluation of vaccine science introduces a precedent: U.S. contributions to multilateral health bodies may now be contingent on those bodies aligning with the administration's scientific positions. Gavi's governance structure, which brings together donor governments, recipient countries, vaccine manufacturers, and civil society organizations, was designed to insulate procurement decisions from any single donor's policy preferences. A conditionality rooted in scientific methodology challenges that design principle.

Oversight concerns also form part of the backdrop. USAID OIG audits have previously identified weaknesses in USAID's global health oversight and made recommendations for corrective action, per the OIG's semi-annual report. Those findings, while focused on implementation gaps rather than policy direction, will likely factor into how Congress and oversight bodies track the disbursed Gavi funds.

For Gavi's implementing partners and recipient governments, the reinstatement restores a critical funding pipeline after months of uncertainty. The phase-out had already begun, meaning procurement schedules and campaign planning in multiple countries had been disrupted. The agreement to disburse does not automatically undo that disruption; operational recovery will depend on the disbursement timeline and the scope of funds ultimately released.

The trajectory from threatened termination to conditional reinstatement reflects a policy process still in motion. Whether the funding resumption marks a durable recommitment to Gavi or a temporary reprieve pending further conditions is an open question for the donor community and the countries that depend on the alliance's purchasing power.